Benzinga's Top Ratings Upgrades, Downgrades For November 16, 2022

Upgrades

According to Janney Montgomery Scott, the prior rating for Consolidated Water Co Ltd CWCO was changed from Neutral to Buy. In the third quarter, Consolidated Water Co showed an EPS of $0.05, compared to $0.09 from the year-ago quarter. The stock has a 52-week-high of $20.58 and a 52-week-low of $9.01. At the end of the last trading period, Consolidated Water Co closed at $13.70.
According to Benchmark, the prior rating for Tencent Music Entertainment Group TME was changed from Hold to Buy. In the third quarter, Tencent Music Enter Gr showed an EPS of $0.12, compared to $0.09 from the year-ago quarter. The stock has a 52-week-high of $7.66 and a 52-week-low of $2.95. At the end of the last trading period, Tencent Music Enter Gr closed at $5.81.
For Lincoln National Corp LNC, Goldman Sachs upgraded the previous rating of Neutral to Buy. For the third quarter, Lincoln National had an EPS of $1.39, compared to year-ago quarter EPS of $1.62. The stock has a 52-week-high of $76.40 and a 52-week-low of $32.59. At the end of the last trading period, Lincoln National closed at $34.16.
Deutsche Bank upgraded the previous rating for Cabot Corp CBT from Hold to Buy. For the fourth quarter, Cabot had an EPS of $1.55, compared to year-ago quarter EPS of $1.11. At the moment, the stock has a 52-week-high of $78.62 and a 52-week-low of $53.32. Cabot closed at $72.75 at the end of the last trading period.
Atlantic Equities upgraded the previous rating for Xylem Inc XYL from Neutral to Overweight. Xylem earned $0.79 in the third quarter, compared to $0.63 in the year-ago quarter. The stock has a 52-week-high of $121.05 and a 52-week-low of $72.08. At the end of the last trading period, Xylem closed at $112.13.
Wells Fargo upgraded the previous rating for Oscar Health Inc OSCR from Equal-Weight to Overweight. Oscar Health earned $0.91 in the third quarter, compared to $1.02 in the year-ago quarter. At the moment, the stock has a 52-week-high of $10.53 and a 52-week-low of $2.34. Oscar Health closed at $2.89 at the end of the last trading period.

See all analyst ratings upgrades.

Downgrades

Chardan Capital downgraded the previous rating for Evelo Biosciences Inc EVLO from Buy to Neutral. Evelo Biosciences earned $0.28 in the third quarter, compared to $0.63 in the year-ago quarter. At the moment, the stock has a 52-week-high of $6.83 and a 52-week-low of $1.42. Evelo Biosciences closed at $2.19 at the end of the last trading period.
B. Riley Securities downgraded the previous rating for Spectrum Pharmaceuticals Inc SPPI from Buy to Neutral. Spectrum Pharmaceuticals earned $0.12 in the third quarter, compared to $0.16 in the year-ago quarter. The current stock performance of Spectrum Pharmaceuticals shows a 52-week-high of $1.62 and a 52-week-low of $0.36. Moreover, at the end of the last trading period, the closing price was at $0.52.
According to UBS, the prior rating for Advance Auto Parts Inc AAP was changed from Buy to Neutral. In the third quarter, Advance Auto Parts showed an EPS of $2.84, compared to $3.21 from the year-ago quarter. At the moment, the stock has a 52-week-high of $244.55 and a 52-week-low of $154.46. Advance Auto Parts closed at $183.94 at the end of the last trading period.
For Rocket Companies Inc RKT, Argus Research downgraded the previous rating of Hold to Sell. In the third quarter, Rocket Companies showed an EPS of $0.08, compared to $0.57 from the year-ago quarter. The stock has a 52-week-high of $15.26 and a 52-week-low of $5.97. At the end of the last trading period, Rocket Companies closed at $8.38.
JonesTrading downgraded the previous rating for Inhibikase Therapeutics Inc IKT from Buy to Hold. In the third quarter, Inhibikase Therapeutics showed an EPS of $0.18, compared to $0.18 from the year-ago quarter. The current stock performance of Inhibikase Therapeutics shows a 52-week-high of $1.80 and a 52-week-low of $0.44. Moreover, at the end of the last trading period, the closing price was at $0.62.
For Winc Inc WBEV, Canaccord Genuity downgraded the previous rating of Buy to Hold. In the third quarter, Winc showed an EPS of $0.33, compared to $2.55 from the year-ago quarter. The current stock performance of Winc shows a 52-week-high of $8.66 and a 52-week-low of $0.40. Moreover, at the end of the last trading period, the closing price was at $0.45.
According to B. Riley Securities, the prior rating for Infinity Pharmaceuticals Inc INFI was changed from Buy to Neutral. In the third quarter, Infinity Pharmaceuticals showed an EPS of $0.12, compared to $0.12 from the year-ago quarter. At the moment, the stock has a 52-week-high of $2.41 and a 52-week-low of $0.46. Infinity Pharmaceuticals closed at $0.79 at the end of the last trading period.
For Evotec SE EVO, Deutsche Bank downgraded the previous rating of Buy to Hold. At the moment, the stock has a 52-week-high of $23.63 and a 52-week-low of $7.83. Evotec closed at $9.25 at the end of the last trading period.
For Sotera Health Co SHC, Barclays downgraded the previous rating of Equal-Weight to Underweight. For the third quarter, Sotera Health had an EPS of $0.23, compared to year-ago quarter EPS of $0.21. The current stock performance of Sotera Health shows a 52-week-high of $24.90 and a 52-week-low of $5.78. Moreover, at the end of the last trading period, the closing price was at $6.97.
For Unum Group UNM, Goldman Sachs downgraded the previous rating of Buy to Neutral. In the third quarter, Unum showed an EPS of $1.51, compared to $1.03 from the year-ago quarter. The stock has a 52-week-high of $46.64 and a 52-week-low of $24.23. At the end of the last trading period, Unum closed at $40.55.
According to Oppenheimer, the prior rating for Evoqua Water Technologies Corp AQUA was changed from Outperform to Perform. For the fourth quarter, Evoqua Water Technologies had an EPS of $0.45, compared to year-ago quarter EPS of $0.31. At the moment, the stock has a 52-week-high of $48.49 and a 52-week-low of $30.44. Evoqua Water Technologies closed at $44.79 at the end of the last trading period.
According to Raymond James, the prior rating for The Home Depot Inc HD was changed from Outperform to Market Perform. Home Depot earned $4.24 in the third quarter, compared to $3.92 in the year-ago quarter. The current stock performance of Home Depot shows a 52-week-high of $417.84 and a 52-week-low of $264.51. Moreover, at the end of the last trading period, the closing price was at $311.93.
According to UBS, the prior rating for Corteva Inc CTVA was changed from Buy to Neutral. Corteva earned $0.12 in the third quarter, compared to $0.14 in the year-ago quarter. The current stock performance of Corteva shows a 52-week-high of $68.43 and a 52-week-low of $43.74. Moreover, at the end of the last trading period, the closing price was at $66.72.
According to Keybanc, the prior rating for Rapid7 Inc RPD was changed from Overweight to Sector Weight. In the third quarter, Rapid7 showed an EPS of $0.14, compared to $0.06 from the year-ago quarter. The stock has a 52-week-high of $118.42 and a 52-week-low of $26.48. At the end of the last trading period, Rapid7 closed at $30.92.

See all analyst ratings downgrades.

Initiations

With an Outperform rating, Evercore ISI Group initiated coverage on Lithium Americas Corp LAC. The price target seems to have been set at $35.00 for Lithium Americas. For the third quarter, Lithium Americas had an EPS of $0.30, compared to year-ago quarter EPS of $0.14. The stock has a 52-week-high of $40.39 and a 52-week-low of $18.89. At the end of the last trading period, Lithium Americas closed at $26.39.
Truist Securities initiated coverage on AbCellera Biologics Inc ABCL with a Buy rating. The price target for AbCellera Biologics is set to $29.00. AbCellera Biologics earned $0.08 in the third quarter, compared to $0.08 in the year-ago quarter. At the moment, the stock has a 52-week-high of $14.97 and a 52-week-low of $5.42. AbCellera Biologics closed at $14.49 at the end of the last trading period.
Needham initiated coverage on Altair Engineering Inc ALTR with a Buy rating. The price target for Altair Engineering is set to $60.00. In the third quarter, Altair Engineering showed an EPS of $0.05, compared to $0.11 from the year-ago quarter. The stock has a 52-week-high of $78.38 and a 52-week-low of $43.17. At the end of the last trading period, Altair Engineering closed at $50.07.
Edward Jones initiated coverage on Synopsys Inc SNPS with a Hold rating. In the third quarter, Synopsys showed an EPS of $2.10, compared to $1.81 from the year-ago quarter. At the moment, the stock has a 52-week-high of $391.17 and a 52-week-low of $255.02. Synopsys closed at $334.20 at the end of the last trading period.
JMP Securities initiated coverage on Spruce Biosciences Inc SPRB with a Market Outperform rating. The price target for Spruce Biosciences is set to $8.00. For the third quarter, Spruce Biosciences had an EPS of $0.48, compared to year-ago quarter EPS of $0.49. At the moment, the stock has a 52-week-high of $4.69 and a 52-week-low of $0.96. Spruce Biosciences closed at $1.05 at the end of the last trading period.
RBC Capital initiated coverage on Mind Medicine Inc MNMD with an Outperform rating. The price target for Mind Medicine is set to $5.00. Mind Medicine earned $0.56 in the third quarter, compared to $0.60 in the year-ago quarter. At the moment, the stock has a 52-week-high of $23.10 and a 52-week-low of $2.35. Mind Medicine closed at $2.86 at the end of the last trading period.
With a Neutral rating, Credit Suisse initiated coverage on Microchip Technology Inc MCHP. The price target seems to have been set at $85.00 for Microchip Technology. Microchip Technology earned $1.46 in the second quarter, compared to $1.07 in the year-ago quarter. The stock has a 52-week-high of $88.97 and a 52-week-low of $54.33. At the end of the last trading period, Microchip Technology closed at $76.94.
Credit Suisse initiated coverage on Monolithic Power Systems Inc MPWR with an Outperform rating. The price target for Monolithic Power Systems is set to $475.00. Monolithic Power Systems earned $3.53 in the third quarter, compared to $2.06 in the year-ago quarter. At the moment, the stock has a 52-week-high of $541.39 and a 52-week-low of $301.69. Monolithic Power Systems closed at $405.03 at the end of the last trading period.
Credit Suisse initiated coverage on Marvell Technology Inc MRVL with an Outperform rating. The price target for Marvell Tech is set to $56.00. Marvell Tech earned $0.57 in the second quarter, compared to $0.34 in the year-ago quarter. At the moment, the stock has a 52-week-high of $91.78 and a 52-week-low of $35.30. Marvell Tech closed at $44.70 at the end of the last trading period.
Credit Suisse initiated coverage on NXP Semiconductors NV NXPI with a Neutral rating. The price target for NXP Semiconductors is set to $195.00. For the third quarter, NXP Semiconductors had an EPS of $3.81, compared to year-ago quarter EPS of $2.84. The current stock performance of NXP Semiconductors shows a 52-week-high of $234.90 and a 52-week-low of $132.08. Moreover, at the end of the last trading period, the closing price was at $174.81.
Credit Suisse initiated coverage on Qualcomm Inc QCOM with an Outperform rating. The price target for Qualcomm is set to $150.00. Qualcomm earned $3.13 in the fourth quarter, compared to $2.55 in the year-ago quarter. The stock has a 52-week-high of $193.58 and a 52-week-low of $101.93. At the end of the last trading period, Qualcomm closed at $126.02.
Credit Suisse initiated coverage on Micron Technology Inc MU with an Outperform rating. The price target for Micron Technology is set to $78.00. In the fourth quarter, Micron Technology showed an EPS of $1.45, compared to $2.42 from the year-ago quarter. The current stock performance of Micron Technology shows a 52-week-high of $98.45 and a 52-week-low of $48.45. Moreover, at the end of the last trading period, the closing price was at $63.10.